Bonsai Biotherapeutics AB
559523-4435ActiveBiotherapeutics operations assumed following major corporate merger completion.
Overview
- 10–19
- Employees
- Unknown
- Revenue
- 2025
- Founded
Description
The organization detailed here represents the operational successor to Toleranzia AB following a formal merger with Flerie AB. This complex corporate restructuring, finalized in August 2025, involved the dissolution of Toleranzia and the transfer of all its assets and liabilities. These undertakings...
Tags
Keywords
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559523443501
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in FunnelfeedrMoligo Technologies AB
4 employeesMoligo provides ultrapure, long single-stranded DNA synthesis services at scale.
Theralia AB
0 employeesPioneering biotech revolutionizing drug delivery via TOUCAN technology.
Cell4Cure AB
Pioneering antigen-specific immune tolerance therapies using engineered dendritic cells.
Disruptive Pharma AB (publ)
5–9 employeesSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
LIDDS AB
1–4 employeesSwedish drug delivery company utilizing proprietary NanoZolid technology platform.
Browse More
Bonsai Biotherapeutics AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo